Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, Liège, Belgium; Faculty of Medicine, Liège University, Liège, Belgium.
Laboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, Liège, Belgium.
Biochem Pharmacol. 2020 Sep;179:113963. doi: 10.1016/j.bcp.2020.113963. Epub 2020 Apr 8.
Eosinophils are a type of granulated innate immune cells that have long been implicated in a specific type of asthma, referred to as eosinophilic asthma. Several immunotherapeutics that target and deplete eosinophils or limit their numbers are currently widely used and provide improved disease outcome in severe eosinophilic asthma. Current clinical results provide conclusive evidence of a generally detrimental role of eosinophils in asthma. Yet, a small but growing body of reports suggests that eosinophils may be more diverse than currently appreciated. In this review, we explore pre-clinical and clinical evidence that suggests the existence of eosinophil subsets with potentially distinct functional roles in asthma. We conclude by discussing state-of-the-art strategies for deciphering heterogeneity of this complex cell type, and argue this knowledge could translate into the improved personalized treatment of severe eosinophilic asthma.
嗜酸性粒细胞是一种颗粒状先天免疫细胞,长期以来一直被认为与一种特定类型的哮喘有关,称为嗜酸性粒细胞性哮喘。目前有几种针对嗜酸性粒细胞的免疫疗法被广泛应用,这些疗法可以靶向和消耗嗜酸性粒细胞或限制其数量,从而改善严重嗜酸性粒细胞性哮喘的疾病预后。目前的临床结果提供了确凿的证据,证明嗜酸性粒细胞在哮喘中通常具有有害作用。然而,越来越多的报告表明,嗜酸性粒细胞可能比目前所认识的更为多样化。在这篇综述中,我们探讨了临床前和临床证据,这些证据表明在哮喘中存在具有潜在不同功能作用的嗜酸性粒细胞亚群。最后,我们讨论了用于解析这种复杂细胞类型异质性的最新策略,并认为这些知识可以转化为严重嗜酸性粒细胞性哮喘的个体化治疗的改善。